CaDAnCe-101
BeOne Medicines
BeOne Medicines
Merck Sharp & Dohme LLC
Nurix Therapeutics, Inc.
University of Chicago
Gilead Sciences
University of Washington
Eli Lilly and Company
Dana-Farber Cancer Institute
Ascentage Pharma Group Inc.
Newave Pharmaceutical Inc
Schrödinger, Inc.
BeOne Medicines
Eli Lilly and Company
AbbVie
Acerta Pharma BV
Carna Biosciences, Inc.
BeOne Medicines
Mayo Clinic
Accutar Biotechnology Inc
Northwell Health
Boryung Pharmaceutical Co., Ltd
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Memorial Sloan Kettering Cancer Center
Stanford University
Barbara Ann Karmanos Cancer Institute
Roswell Park Cancer Institute
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Fred Hutchinson Cancer Center
BeiGene
Nurix Therapeutics, Inc.
Bio-Path Holdings, Inc.
Calibr, a division of Scripps Research
Nkarta, Inc.
Xencor, Inc.
Calibr, a division of Scripps Research
Roswell Park Cancer Institute
University of Rochester
Stanford University
VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Mayo Clinic
University of Nebraska
Stanford University
Dartmouth-Hitchcock Medical Center
Agenus Inc.
University of Nebraska
Canadian Cancer Trials Group
Eastern Cooperative Oncology Group
Abramson Cancer Center at Penn Medicine
Hutchmed